# Beneficial Effects of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure With Preserved Ejection Fraction and Diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/beneficial-effects-of-dipeptidyl-peptidase-4-inhibitors-on-heart-failure-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nobuyuki Enzan,Shouji Matsushima,Hidetaka Kaku,Takeshi Tohyama,Takuya Nagata,Tomomi Ide,Hiroyuki Tsutsui |
| Citations | 34 |
| DOI | 10.1016/j.jacasi.2022.09.015 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.jacasi.2022.09.015 |
| OpenAlex ID | https://openalex.org/W4313529540 |
| PMID | 36873765 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Nobuyuki Enzan](https://scholariq.org/researchers/nobuyuki-enzan/)
- [Takeshi Tohyama](https://scholariq.org/researchers/takeshi-tohyama/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.